FWBI - First Wave BioPharma - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

First Wave BioPharma's activity chart (see below) currently has 5 price targets and 17 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 218.33 days.

Most recent stock forecast was given by from HC WAINWRIGHT on 25-Mar-2024. First documented stock forecast 17-Oct-2018.

Best performing analysts who are covering FWBI - First Wave BioPharma:

Jonathan Aschoff Yi Chen Jason Mccarthy Leland Gershell

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 25-Mar-2024

2 years 5 months 21 days ago
(25-Mar-2024)

2/2 (100%)

$-31.6 (-69.30%)

82

Buy Since 01-Apr-2021

2 years 8 months 12 days ago
(03-Jan-2024)

2/2 (100%)

$-4174.83 (-16.58%)

100

Hold Since 10-Dec-2021

$12600

4 years 9 months 5 days ago
(10-Dec-2021)

1/1 (100%)

$-16892.3 (-57.28%)

735

Buy Since 17-Oct-2018

$33600

$33597.02 (1127416.75%)

7 years 6 months 20 days ago
(26-Feb-2019)

1/1 (100%)

$-54931.46 (-62.05%)

211

Show more analysts

Please expand the browser size to see the chart

What is FWBI (First Wave BioPharma) average time for price targets to be met?

On average it took 218 days for the stock forecasts to be reached, with an average price target met ratio of 100%.

Which analyst most recently updated their price target on FWBI (First Wave BioPharma)?

Which analyst has the current lower performing score on FWBI (First Wave BioPharma) with a proven track record?

LELAND GERSHELL

Which analyst has the most public recommendations on FWBI (First Wave BioPharma)?

has 0 price targets and 0 ratings on FWBI

Which analyst is the currently most bullish on FWBI (First Wave BioPharma)?

Leland Gershell with the highest potential upside of $33597.02

Which analyst is the currently most reserved on FWBI (First Wave BioPharma)?

Jonathan Aschoff with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?